Ovarian Cancer Trial, Recruiting NCT06760923 Sponsor: Xiangya Hospital of Central South University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06760923
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who are in a gynaecology ward and are scheduled to have surgery.
  • Women who have been given an initial diagnosis of a pelvic mass or malignant ascites (fluid build-up in the abdomen) that may be ovarian cancer, OR an initial diagnosis of an ovarian cyst, blocked fallopian tube, uterine fibroids, or a condition called uterine adenomyosis (a non-cancerous gynaecological condition).
  • People who are 18 years of age or older.
  • People who are willing to take part and have signed a consent form agreeing to participate.

Who may not be able to join:

  • People who have previously been diagnosed with any type of cancer.
  • People who have a history of chronic kidney disease or reduced kidney function.
  • People who have already received, or are currently receiving, treatment for the condition that led to their hospital admission.
  • People whose diagnosis has not been clearly confirmed by tissue or pathology testing.
  • People who change their mind and withdraw their consent to participate.
  • People who are unable to provide a suitable urine sample.
  • People whom the research team determines should be withdrawn from the study for any other reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 0731-89753999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xiangya Hospital of Central South University
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Pathological diagnosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov